Point of Care (PoC) Molecular Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Point of Care (PoC) Molecular Diagnostics Market- Key Findings, 2020

3. Strategic Imperatives on Global Point of Care (PoC) Molecular Diagnostics Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Point of Care (PoC) Molecular Diagnostics Companies

4. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Application

• 4.1 Infectious Diseases
• 4.2 Oncology
• 4.3 Hematology
• 4.4 Prenatal Testing
• 4.5 Endocrinology
• 4.6 Others

5. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Technology

• 5.1 PCR Based
• 5.2 Genetic Sequencing Bassed
• 5.3 Hybridization Based
• 5.4 Microarray Based

6. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by End User

• 6.1 Laboratories
• 6.2 Hospitals
• 6.3 Homecare
• 6.4 Others

7 Asia Pacific Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026

• 7.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Asia Pacific market
• 7.2 Top Applications contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics
• 7.3 Top countries contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics

8 Europe Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026

• 8.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Europe market
• 8.2 Top Applications contributing to Europe Point of Care (PoC) Molecular Diagnostics
• 8.3 Top countries contributing to Europe Point of Care (PoC) Molecular Diagnostics

9 North America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026

• 9.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to North America market
• 9.2 Top Applications contributing to North America Point of Care (PoC) Molecular Diagnostics
• 9.3 Top countries contributing to North America Point of Care (PoC) Molecular Diagnostics

10 South and Central America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026

• 10.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to South and Central America market
• 10.2 Top Applications contributing to South and Central America Point of Care (PoC) Molecular Diagnostics
• 10.3 Top countries contributing to South and Central America Point of Care (PoC) Molecular Diagnostics

11 Middle East Africa Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026

• 11.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Middle East Africa market
• 11.2 Top Applications contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics
• 11.3 Top countries contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics

12 Business Profiles of Leading Companies

• 12.1 Business Description, SWOT and Financial Analysis of Companies in Point of Care (PoC) Molecular Diagnostics market
• 12.2 Abaxis
• 12.3 Abbott Laboratories
• 12.4 Alere Inc
• 12.5 Bayer Healthcare
• 12.6 BioMerieux
• 12.7 Bio-Rad Laboratories
• 12.8 Dako
• 12.9 Danaher Corporation
• 12.10 Nipro Diagnostics
• 12.11 Nova Biomedical

13 Recent Industry Developments

14 Appendix

• 14.1 OGAnalysis Expertise
• 14.2 Sources and Methodology